📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Rewrite Therapeutics

1.1 - Company Overview

Rewrite Therapeutics Logo

Rewrite Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Rewrite Therapeutics

GenSight Biologics Logo

GenSight Biologics

HQ: France Website
  • Description: Provider of gene therapy-based treatments for retinal degenerative diseases. Develops candidates such as GS010 (lenadogene nolparvovec) for Leber Hereditary Optic Neuropathy (LHON) and GS030, an optogenetics-based therapy in Phase I/II trials, leveraging mitochondrial targeting sequence (MTS) technology and optogenetics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GenSight Biologics company profile →
Enancio Logo

Enancio

HQ: France Website
  • Description: Provider of high-speed, efficient genomic data compression and decompression, complementing Illumina’s other informatics solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enancio company profile →
Phthisis Diagnostics Logo

Phthisis Diagnostics

HQ: United States Website
  • Description: Provider of molecular diagnostics products for various infectious diseases, leveraging molecular technology to deliver superior quality, ease of use, and cost savings for laboratories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phthisis Diagnostics company profile →
ViroGates Logo

ViroGates

HQ: Denmark Website
  • Description: Provider of suPARnostic blood test products for better triaging in hospitals, primarily used in emergency departments for risk stratification to improve patient care, reduce healthcare costs, and empower clinical staff.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ViroGates company profile →
ReadCoor Logo

ReadCoor

HQ: United States Website
  • Description: Provider of the first true spatial multi-omic platform (RC2) that simultaneously detects and reads sequences, serving a global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and facilitate the creation of new therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ReadCoor company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Rewrite Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Rewrite Therapeutics

2.2 - Growth funds investing in similar companies to Rewrite Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Rewrite Therapeutics

4.2 - Public trading comparable groups for Rewrite Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Rewrite Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Rewrite Therapeutics

What does Rewrite Therapeutics do?

Rewrite Therapeutics is a provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.

Who are Rewrite Therapeutics's competitors?

Rewrite Therapeutics's competitors and similar companies include GenSight Biologics, Enancio, Phthisis Diagnostics, ViroGates, and ReadCoor.

Where is Rewrite Therapeutics headquartered?

Rewrite Therapeutics is headquartered in United States.

How many employees does Rewrite Therapeutics have?

Rewrite Therapeutics has 1,000 employees 🔒.

When was Rewrite Therapeutics founded?

Rewrite Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Rewrite Therapeutics in?

Rewrite Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Rewrite Therapeutics

Who are the top strategic acquirers in Rewrite Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Rewrite Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Rewrite Therapeutics?

Top strategic M&A buyers groups and sectors for Rewrite Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Rewrite Therapeutics's sector and industry vertical

Which are the top PE firms investing in Rewrite Therapeutics's sector and industry vertical?

Top PE firms investing in Rewrite Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Rewrite Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Rewrite Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Rewrite Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Rewrite Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Rewrite Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Rewrite Therapeutics?

The key public trading comparables and valuation benchmarks for Rewrite Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Rewrite Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Rewrite Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Rewrite Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Rewrite Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Rewrite Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Rewrite Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Rewrite Therapeutics